Day One Biopharmaceuticals, Inc. (DAWN)
Apr 21, 2026 - DAWN was delisted (reason: acquired by Servier)
21.53
+0.04 (0.19%)
Inactive · Last trade price
on Apr 22, 2026
DAWN Employees
Day One Biopharmaceuticals had 178 employees as of December 31, 2025. The number of employees decreased by 3 or -1.66% compared to the previous year.
Employees
178
Change (1Y)
-3
Growth (1Y)
-1.66%
Revenue / Employee
$888,663
Profits / Employee
-$602,933
Market Cap
2.22B
Employees Chart
DAWN News
- 5 days ago - Servier completes the acquisition of Day One Biopharmaceuticals - PRNewsWire
- 7 weeks ago - Are DAWN and TALK Obtaining Fair Deals for their Shareholders? - PRNewsWire
- 7 weeks ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN) - Newsfile Corp
- 7 weeks ago - Is there any upside left in DAWN stock as it soars 65%? - Invezz
- 7 weeks ago - Day One Shares Surge After $2.5B Servier Deal - Benzinga
- 7 weeks ago - Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion - Reuters
- 7 weeks ago - Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio - GlobeNewsWire
- 2 months ago - Day One Biopharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts